Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the ...

An NIH announcement Friday cutting billions in biomedical research, a federal funding review and DEI prohibitions have left ...

Jan. 27, 2025 — Basal cell carcinomas ... an endolysosomal ion channel promotes tumor development in skin ... Study Uncovers Potential New Target for Treatment of Chronic, Debilitating Skin ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

"These cells can be easily modified in a lab and re-implanted, making them a highly adaptable platform for cell therapy, including cancer treatment." Unlike many other engineered cell therapies ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

Scientists from Rice University and their collaborators have unveiled a groundbreaking technique to combat cancer cells, ...